@Xenon Pharmaceuticals Inc. is excited to engage with the broad #epilepsy community at #AES2024 and share new long-term azetukalner data from our ongoing #X-TOLE OLE study. Read details here: https://lnkd.in/gGZDTKmk #neuroscience #neurology #epilepsy #ionchannels #Kv7
Xenon Pharmaceuticals Inc.
Biotechnology Research
Burnaby, BC 15,484 followers
A neuroscience-focused biopharmaceutical company
About us
Who We Are: Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team. What We Do: We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy and depression. Our flagship azetukalner program represents the most advanced potassium channel modulator in clinical development for multiple indications. Building upon the positive results and compelling data from our Phase 2b “X-TOLE” study in adult patients with focal epilepsy, our Phase 3 epilepsy program includes multiple clinical trials evaluating azetukalner in patients with focal onset seizures and primary generalized tonic-clonic seizures. In 2024, we are planning to initiate a Phase 3 azetukalner program in major depressive disorder, based on topline data from our Phase 2 “X-NOVA” clinical trial. In addition, we are proud of the leading-edge science coming out of our discovery labs, including early-stage research programs that leverage our extensive ion channel expertise and drug discovery capabilities to identify validated drug targets and develop new product candidates. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
- Website
-
http://www.xenon-pharma.com
External link for Xenon Pharmaceuticals Inc.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Burnaby, BC
- Type
- Public Company
- Specialties
- drug discovery, ion channels, neurology, epilepsy, drug development, neuroscience, biotechnology, biopharmaceuticals, seizures, focal onset seizures, MDD, psychiatry, depression, neuropsychiatry, tonic-clonic seizures, FOS, PGTSC, sodium channels, and potassium channels
Locations
-
Primary
Get directions
3650 Gilmore Way
Burnaby, BC V5G 4W8, CA
-
Get directions
117 Kendrick Street
Suite 200
Needham, MA 02494, US
Employees at Xenon Pharmaceuticals Inc.
Updates
-
We are grateful for the many opportunities to have meaningful discussions about our science and pipeline during our Scientific Exhibit and five poster presentations at #AES2024 this year. Thank you to everyone who met with the #Xenon team at our booth and accompanying Mindfulness Zone - where we highlighted the #mental #health burdens associated with #epilepsy. Learn more about us: https://lnkd.in/edfxGASR #neuroscience #neurology #epilepsy #ionchannels #Kv7 #XENEDreamTeam
-
Xenon Pharmaceuticals Inc. presented five posters at #AES2024 including new interim long-term data from the ongoing #X-TOLE #OLE study of #azetukalner in focal onset #seizures; findings around #mental #health and #comorbidity burdens of #FOS; and new #preclinical data from the Company’s #Nav1.1 program. View posters here: https://lnkd.in/gNGATBvz
-
Xenon Pharmaceuticals Inc. today announced multiple poster presentations at the upcoming American #Epilepsy Society Annual Meeting (#AES 2024), taking place December 6-10, 2024 at the Los Angeles Convention Center in Los Angeles, CA. More details here: https://lnkd.in/gsV3YCXE
-
Xenon Pharmaceuticals Inc. is celebrating 10 years listed on #NASDAQ under the ticker symbol #XENE! Thank you to our #shareholders for their support as we strive to discover, develop, and deliver #life-changing #therapeutics for patients in need. #neuroscience #epilepsy #ionchannels #Kv7 #NasdaqListed
-
Xenon Pharmaceuticals Inc. will present at two upcoming #investor #conferences. Read details here: https://lnkd.in/gTHG7msW
-
Xenon Pharmaceuticals Inc. reported its third quarter financial results today. Read details here: https://lnkd.in/g2qced6C #neuroscience #neurology #epilepsy #ionchannels #Kv7 #Q3 #financials
-
Xenon Pharmaceuticals Inc. will report its third quarter #financial #results on Tuesday, November 12th. Join us for a #webcast beginning at 4:30 pm ET. More details here: https://lnkd.in/gkNa84ad
-
Xenon Pharmaceuticals Inc. reposted this
During NEAM and every day, Xenon recognizes our PAG partners who promote education, policy, and research in Epilepsy. Epilepsy Foundation, Epilepsy Foundation New England #NEAM2024, #ShareYourPurplePower
-
During NEAM and every day, Xenon recognizes our PAG partners who promote education, policy, and research in Epilepsy. Epilepsy Foundation, Epilepsy Foundation New England #NEAM2024, #ShareYourPurplePower